SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax
Jan 19, 20230
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
David Dodd/GeoVax GeoVax Labs is a clinical-stage biotechnology company developing novel therapies and vaccines for cancers and many of the world's most threatening infectious diseases. The company's lead program in oncology is a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, presently in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax's […]
The post SIMON SAYS, LET’S TALK BUSINESS: David Dodd with GeoVax appeared first on Business RadioX ®.
For the best experience, listen in Metacast app for iOS or Android